Veradigm | MDRX - Debt


Veradigm reported $200.33M in Debt for its fiscal quarter ending in September of 2022.





Debt Change Date
Alcidion AUD 1.37M 329K Dec/2024
Ambu A/S DKK 551M 6M Mar/2026
Amplifon EUR 1.79B 31.89M Mar/2026
Cardinal Health USD 8.89B 30M Jun/2026
Centene USD 16.1B 266M Jun/2026
Charles River Laboratories USD 3.06B 485.84M Mar/2026
Cigna USD 30.9B 563M Mar/2026
Coloplast 18.67B 35M Sep/2023
Convatec Group USD 1.2B 210.3M Dec/2024
CVS Health USD 61.41B 16.94B Jun/2026
Diasorin EUR 769.18M 97.18M Jun/2025
Elevance Health USD 31.04B 798M Jun/2026
General Electric Aerospace USD 19.16B 1.12B Jun/2026
Gulf Medical Proj AED 7.67M 1.75M Mar/2025
Humana USD 14.25B 254M Jun/2026
IQVIA Holdings USD 16.24B 408M Jun/2026
Laboratory Of America USD 7.24B 714.6M Mar/2026
Maximus USD 1.63B 42.48M Mar/2026
McKesson USD 8.61B 10M Mar/2026
Med Life RON 2.02B 74.6M Mar/2026
Molina Healthcare USD 3.95B 3M Mar/2026
Omnicell USD 202.18M 2.16M Mar/2026
Oriola-kd EUR 76.1M 13M Dec/2024
Owens Minor USD 1.95B 91.18M Mar/2025
Quest Diagnostics USD 6.41B 179M Mar/2026
Rede D'or Sao Luiz BRL 52.46B 2.5B Mar/2026
Siemens Healthineers EUR 821M 57M Mar/2026
Sonova Holding CHF 1.91B 130.9M Jun/2023
Supermax Corporation Bhd MYR 163.09M 1.07M Mar/2026
UnitedHealth USD 73.33B 4.59B Jun/2026
Veeva Systems USD 103.07M 7.21M Mar/2026
Veradigm USD 200.33M 431K Sep/2022
Xerox USD 3.3B 101M Mar/2025